Additionally, aminorex and sibutramine have been linked to cardiovascular toxicity, pulmonary hypertension, and a rise in non-fatal cardiovascular incidents [37, 39, 43, 45, 46]
ELIXA trial included patients with recent cardiovascular event (patients with acute coronary syndrome 180 days before randomization), and although there was no benefit in MACE reduction in lixisenatide treated patients compared to placebo, results revealed cardiovascular safety of lixisenatide in this specific high risk population ( Dose-dependent effect for oral semaglutide was assessed and proven in Japanese PIONEER 9 trial, where greater reduction of HbA1c and weight loss was achieved with higher dose of oral semaglutide compared to placebo and 0.9 mg liraglutide ( Mechanisms related to cardiovascular effects of GLP-1 receptor agonists The cardiovascular effects of GLP-1 receptor agonists in CVOTs can be attributed to several mechanisms
The benzyl alcohol inhibits microbial growth, allowing the same vial of bacteriostatic water to be punctured and used multiple times across a 28-day window without compromising sterility
Seventeen studies including observational studies, experimental studies, and narrative reviews were included in the review